Treatment parameters for beta and gamma devices in peripheral endovascular brachytherapy.

[1]  H. Ing,et al.  A short atlas of beta-ray spectra , 1983 .

[2]  D. Liermann,et al.  Endovascular irradiation--a new method to avoid recurrent stenosis after stent implantation in peripheral arteries: technique and preliminary results. , 1994, International journal of radiation oncology, biology, physics.

[3]  J F Williamson,et al.  Monte Carlo aided dosimetry of the microselectron pulsed and high dose-rate 192Ir sources. , 1995, Medical physics.

[4]  Wim Dries.  Monte Carlo calculated dose distribution for endovascular HDR brachytherapy with Ir-192. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  R. Pötter,et al.  Brachytherapy for prophylaxis of restenosis after long-segment femoropopliteal angioplasty: pilot study. , 1998, Radiology.

[6]  J. Galvin,et al.  Radiochromic film dosimetry: recommendations of AAPM Radiation Therapy Committee Task Group 55. American Association of Physicists in Medicine. , 1998, Medical physics.

[7]  Dosimetry calculation for a novel phosphorus-32-impregnated balloon angioplasty catheter for intravascular brachytherapy. , 1999, Cardiovascular radiation medicine.

[8]  G. Quong,et al.  Dose errors in the near field of an HDR brachytherapy stepping source , 1999, Physics in medicine and biology.

[9]  R. Firestone,et al.  WWW Table of Radioactive Isotopes , 1999 .

[10]  S. Jani,et al.  Endovascular brachytherapy for peripheral vascular disease. , 1999, Seminars in radiation oncology.

[11]  R Nath,et al.  Intravascular brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group no. 60. American Association of Physicists in Medicine. , 1999, Medical physics.

[12]  R. Pötter,et al.  Intraarterial (192)Ir high-dose-rate brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2-trial radiotherapy parameters and risk factors analysis. , 2000, International journal of radiation oncology, biology, physics.

[13]  R Pötter,et al.  Endovascular Brachytherapy for Prophylaxis of Restenosis After Femoropopliteal Angioplasty: Results of a Prospective Randomized Study , 2000, Circulation.

[14]  K. Bratengeier.  Ein schneller Algorithmus zur homogenen Ir-192-Afterloading-Bestrahlung zylindrischer Zielflächen , 2001 .

[15]  J J Mazeron,et al.  Prescribing, recording, and reporting in endovascular brachytherapy. Quality assurance, equipment, personnel and education. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  R. Pötter,et al.  Endovascular brachytherapy for prophylaxis against restenosis after long-segment femoropopliteal placement of stents: initial results. , 2001, Radiology.

[17]  W. Weintraub,et al.  Intravascular radiation therapy after balloon angioplasty of narrowed femoropopliteal arteries to prevent restenosis: results of the PARIS feasibility clinical trial. , 2001, Journal of vascular and interventional radiology : JVIR.

[18]  P. Serruys,et al.  Inaccuracy in manual multisegmental irradiation in coronary arteries. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  C. Kirisits,et al.  Possible impact of iridium-192 source centering on restenosis rate after femoro-popliteal angioplasty and endovascular brachytherapy in Vienna-2 study. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  Richard R. Heuser,et al.  Randomized Trial of 90Sr/90Y β-Radiation Versus Placebo Control for Treatment of In-Stent Restenosis , 2002 .

[21]  D. Flühs,et al.  DGMP guideline for medical physical aspects of intravascular brachytherapy. Part II: Samples and examples. , 2002, Zeitschrift fur medizinische Physik.

[22]  U. Quast,et al.  Deutsche Gesellschaft für Medizinische Physik e.V. , 2002 .

[23]  C. Kirisits,et al.  Determination and application of the reference isodose length (RIL) for commercial endovascular brachytherapy devices. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[24]  C. Kirisits,et al.  Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 multicenter study , 2003 .

[25]  Monte Carlo dose characterization of a new 90Sr/90Y source with balloon for intravascular brachytherapy. , 2002, Medical physics.

[26]  G. Stone,et al.  Usefulness of beta radiation for de novo and in-stent restenotic lesions in saphenous vein grafts. , 2003, American Journal of Cardiology.

[27]  I. Baumgartner,et al.  Endovascular Brachytherapy after Percutaneous Transluminal Angioplasty of Recurrent Femoropopliteal Obstructions , 2003, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[28]  C. Kirisits,et al.  Quality assurance in intracoronary brachytherapy. Recommendations for determining the planning target length to avoid geographic miss. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  C. Soares.  Radiochromic film dosimetry , 2006 .